Functional Disorders of the Gastrointestinal Tract During the Pandemic of a New Coronavirus Infection
https://doi.org/10.22416/1382-4376-2022-32-3-52-56
Abstract
Aim. To analyze the literature data devoted to the study of the features of functional gastrointestinal diseases (FGID) during the pandemic of a new coronavirus infection.
Key findings. Measures taken in connection with the pandemic of COVID-19 infection (introduction of lockdown, social isolation) leads to an increase in the level of depression and anxiety and, as a consequence, to an increase in the frequency and prevalence of functional dyspepsia (FD) and irritable bowel syndrome (IBS), as well as an increase in the severity of clinical symptoms of these diseases. In turn, the overcoming of COVID-19 infection contributes to an increase in the permeability of the mucous membrane of the gastrointestinal tract and the occurrence of its inflammatory changes, which lead to the development of postinfectious (postcovid) FD and postinfectious (postcovid) IBS.
Conclusion. The problem of functional gastrointestinal diseases during the pandemic of a new coronavirus infection is very important and requires further research.
About the Authors
A. A. Sheptulin
Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Russian Federation
Arkadiy A. Sheptulin — Dr. Sci. (Med.), Prof., Chair of Internal Diseases Propedeutics, Gastroenterology and Hepatology
119435, Moscow, Pogodinskaya str., 1, bld. 1
E. A. Piatenko
Sechenov First Moscow State Medical University (Sechenov University)
Elena A. Piatenko — postgraduate student, Chair of Internal Diseases Propedeutics, Gastroenterology and Hepatology
119435, Moscow, Pogodinskaya str., 1, bld. 1
References
1. Salari N., Hosseinian-Far A., Jalali R., Vaisi-Raygani A., Rasoulpoor S., Mohammadi M., et al. Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis. Global Health. 2020;16(1):57. DOI: 10.1186/s12992-020-00589-w
2. Nakov R., Dimitrova-Yurukova D., Snegarova V., Nakov V., Fox M., Heinrich H. Increased prevalence of gastrointestinal symptoms and disorders of gut-brain interaction during the COVID-19 pandemic: An internet-based survey. Neurogastroenterol Motil. 2022;34(2):e14197. DOI: 10.1111/nmo.14197
3. Otani K., Watanabe T., Higashimori A., Suzuki H., Kamiya T., Shiotani A., et al. A questionnaire-based survey on the impact of the COVID-19 pandemic on gastrointestinal endoscopy in Asia. Digestion. 2022;103(1):7–21. DOI: 10.1159/000520287
4. Oshima T., Siah KT.H.., Yoshimoto T., Miura K., Toshohiko T., Fukui H. et al. Impacts of the COVID-19 pandemic on functional dyspepsia and irritable bowel syndrome: A population-based survey. J Gastroenterol Hepatol. 2021;36(7):1820–7. DOI: 10.1111/jgh.15346
5. Oliviero G., Ruggiero L., D’Antonio E., Gagliardi M., Nunziata R., Di Sarno A., et al. Impact of COVID-19 lockdown on symptoms in patients with functional gastrointestinal disorders: Relationship with anxiety and perceived stress. Neurogastroenterol Motil. 2021 May;33(5):e14092. DOI: 10.1111/nmo.14092
6. Sabate J.-M., Deutsch D., Melchior C., Entremont A., Mion F., Bouchoucha M., et al. COVID-19 pandemic and lockdown stress consequences in people with and without irritable bowel syndrome. Ethics Med Public Health. 2021;18:100660. DOI: 10.1016/j.jemep.2021.100660
7. Xin Zi Quek S., Xiu Ling Loo E., Demutska A., Chun En Chua, Guan Sen Kew , Wong S., et al. Impact of the coronavirus disease 2019 pandemic on irritable bowel syndrome. J Gastroenterol Hepatol. 2021;36(8):2187–97. DOI: 10.1111/jgh.15466
8. Alzahrani M.A., Alshamrani A.S., Ahmassani I.M., Alahmari F.S., Asiri A.H., Alshehri A.M., et al. Coronavirus disease 2019 pandemic stress and its effects on irritable bowel syndrome patients in Saudi Arabia. Medicine (Baltimore). 2020;99(51):e23711. DOI: 10.1097/MD.0000000000023711
9. Xiao Jing Wang, Murphy B., Breen-Lyles M., Fox J. Response to Oliviero et al.' s publication: “Impact of COVID-19 lockdown on symptoms in patients with functional gastrointestinal disorders: Relationship with anxiety and perceived stress”. Neurogastroenterol Motil. 2021:e14207. DOI: 10.1111/nmo.14207
10. Kamp K.J., Levy R.L., Munson S.A., Heitkemper M.M. Impact of COVID-19 on individuals with irritable bowel syndrome and comorbid anxiety and/or depression. J Clin Gastroenterol. 2021.1097/MCG.0000000000001515. DOI: 10.1097/MCG.0000000000001515
11. Schmulson M., Gudino-Zayas M., Hani A., Sociedad Latinoamericana de Neurogastroenterologia. The impact of COVID-19 pandemic on neurogastroenterologists in Latin America: Results of an online survey. J Clin Gastroenterol. 2021;55(8):684–90. DOI: 10.1097/MCG.0000000000001413
12. Gubatan J., Zikos T., Bishop E.S., Wu J., Gottfried A., Becker L., et al. Gastrointestinal symptoms and healthcare utilization have increased among patients with functional gastrointestinal and motility disorders during the COVID-19 pandemic. Neurogastroenterol Motil. 2021;e14243. DOI: 10.1111/nmo.14243
13. Almario C.A., Chey W.D., Spiegel B.M.R. Increased risk of COVID-19 among users of proton pump inhibitors. Аm J Gastroenterol. 2020;115(10):1707–15. DOI: 10.14309/ajg.0000000000000798
14. Farello F., Di Lucia A., Fioravanti B., Tambucci R., Stagi S., Gaudino R. Analysis of the impact of COVID-19 pandemic on functional gastrointestinal disorders among paediatric population. Eur Rev Med Pharmacol Sci. 2021;25(18):5836–42. DOI: 10.26355/eurrev_202109_26802
15. Ghoshal U.C., Ghoshal U., Rahman M.M., Mathur A., Rai S., Akhter M., et al. Post-infection functional gastrointestinal disorders following coronavirus disease-19: A case-control study. J.Gastroenterol Hepatol. 2021 Published online Oct 20. DOI: 10.1111/jgh.15717
16. Velez C., Paz M., Silvernale C., Stratton L.W., Kuo B., Staller K., et al. Factors associated with chronic de novo post-coronavirus disease gastrointestinal disorders in a metropolitan US county. Clin Gastroenterol Hepatol. 2021;S1542-3565(21)01133-2. DOI: 10.1016/j.cgh.2021.10.020
17. Blackett J.W., Li J., Jodorkovsky D., Freedberg D.E. Prevalence and risk factors for gastrointestinal symptoms after recovery from COVID-19 Neurogastroenterol Motil. 2021;e14251. DOI: 10.1111/nmo.14251
18. Ruotolo M., Gagliardi M., Ciacci C., Zingone F., de Santis Ciacci C., Santanicola A., et al. Increased COVID-19 lockdown burden in Italian adults with gastrointestinal diseases. Nutrients. 2021;13 (6):1820. DOI: 10.3390/nu13061820
19. Noviello D., Costantino A., Muscatello A., Bandera A., Consonni D., Vecchi M., et al. Functional gastrointestinal and somatoform symptoms five months after SARS-CoV-2 infection: A controlled cohort study. Neurogastroenterol Motil. 2022;34(2):e14187. DOI: 10.1111/nmo.14187
20. Sheptulin A.A. Diarrhoea in patients with COVID-19. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2020;30(6):51–6 (In Russ.). DOI: 10.22416/1382-4376-2020-30-6-51-56
21. Ghoshal U.C. Postinfection irritable bowel syndrome. Gut Liver. 2021. Published online November 18. DOI: 10.5009/gnl210208
22. Settani C.R., Ianiro G., Ponziani F.R., Bibbo S., Segal J.P., Cammrota G., et al. COVID-19 as a trigger of irritable bowel syndrome: A review of potential mechanisms. World J Gastroenterol. 2021;27(43):7433–45. DOI: 10.3748/wjg.v27.i43.7433
23. Cooney J., Appiahene P., Findlay R., Al-Hillawi L., Rafique K., Laband W., et al. COVID-19 infection causing residual gastrointestinal symptoms — a single UK centre case series. Clin Med (Lond). 2022 Feb 1; clinmed.2021-0522. Published online. DOI: 10.7861/clinmed.2021-0522
Review
For citations:
Sheptulin A.A., Piatenko E.A. Functional Disorders of the Gastrointestinal Tract During the Pandemic of a New Coronavirus Infection. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2022;32(3):52-56. https://doi.org/10.22416/1382-4376-2022-32-3-52-56
Views: 447
Email this article 
